Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
483
Sort by:
mRNA Vaccines and Therapeutics Market Report by Vaccine Type (Self-amplifying mRNA-Based Vaccines, Conventional Non-Amplifying mRNA-Based Vaccines), Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, and Others), Vaccine Manufacturing (In-House, Out-Sourced), Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement), End-User (Hospitals and Clinics, Research Organizations, and Others), and Region 2025-2033
US$ 2,999.00
The global mRNA vaccines and therapeutics market size reached USD 59.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 73.4 Billion by 2033, exhibiting a growth rate (CAG...
June 2025
135 pages
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Vaginal and Vulvar Cancers, Anal Cancer, Oropharyngeal (Head and Neck) Cancers, Genital Warts), By Distribution Channel (Hospitals and Retail Pharmacies, Government Suppliers, Others), By Region, & Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Human Papillomavirus (HPV) Vaccine Market was valued at USD 8.35 Billion in 2024 and is projected to reach USD 13.77 Billion by 2030, growing at a CAGR of 8.65%. This marke...
May 2025
180 pages
Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type (Smartphones, Tablets, Others), By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Digital Vaccine Market was valued at USD 1.28 Billion in 2024 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 7.98%. Digital vaccines represent a b...
May 2025
180 pages
Vaccine Storage and Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Vaccine Storage {Refrigerators, Freezers}, Vaccine Packaging {Cold Boxes, Vials & Ampoules, Corrugated Boxes, Bags, Others}), By Packaging Material (Plastic, Glass, Paper & Paperboard, Others), By End User (Pharma and Biotech Companies, Diagnostic Centers, Clinical Research Organization, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Vaccine Storage and Packaging Market was valued at USD 24.59 Billion in 2024 and is projected to reach USD 46.66 Billion by 2030, registering a CAGR of 11.24%. This market...
May 2025
183 pages
Global Adult Vaccine Market Size study, by Type (Influenza, Pneumococcal, Hepatitis, Zoster, Meningococcal, HPV, DTP, Others), Application (Infectious Diseases, Travel Vaccines, Health Maintenance), and Regional Forecasts 2022-2032
US$ 3,218.00
The Global Adult Vaccine Market is valued approximately at USD 20.51 billion in 2023 and is anticipated to grow with a steady yet compelling growth rate of more than 6.13% over the forecast period 202...
May 2025
285 pages
Global DTaP Vaccine Market - 2025-2033
US$ 4,350.00
Global DTaP Vaccine Market – Industry Trends & Outlook The global DTaP vaccine market reached US$ 5,378.83 Million in 2024 and is expected to reach US$ 11,592.17 Million by 2033, growing at a CAGR of...
May 2025
180 pages
Global MRNA Vaccines and Therapeutics Market - 2025-2033
US$ 4,350.00
Global MRNA Vaccines and Therapeutics Market Size - Industry Trends & Outlook The global MRNA Vaccines and Therapeutics market size reached US$ 410 Million in 2024 and is expected to reach US$ 850.90...
May 2025
168 pages
Global Travelers Vaccines Market - 2025-2033
US$ 4,350.00
Global Travelers Vaccines Market - Industry Outlook & Trends The global traveler's vaccines market reached US$ 4,092.58 million in 2024 and is expected to reach US$ 9,054.68 million by 2033, growing a...
May 2025
180 pages
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Infection (COVID-19, Influenza), By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Respiratory Disease Vaccine Market Growth & Trends The respiratory disease vaccine market size is estimated to reach USD 70.30 bill...
May 2025
100 pages
Human Papillomavirus Vaccines Market Size, Share & Trends Analysis Report By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Anal Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Human Papillomavirus Vaccines Market Growth & Trends The global Human Papillomavirus vaccines market size is expected to reach USD...
May 2025
195 pages
Global Influenza Market – Vaccines and Therapeutics
US$ 4,500.00
... a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining ... analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe ...
April 2025
387 pages
Saudi Arabia Influenza Vaccine Market By Vaccine Type (Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine), By Distribution Channel (Hospital, Retail Pharmacies, Government Suppliers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Influenza Vaccine Market was valued at USD 44.26 Million in 2024 and is expected to reach USD 53.81 Million by 2030 with a CAGR of 3.51% during the forecast period. The vaccine available...
January 2025
85 pages
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
US$ 2,690.00
The global influenza vaccines market is projected to reach US$ 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact...
January 2025
388 pages
Tetanus Toxoid Vaccine Market Size, Share & Trends Analysis Report By Vaccine (Diphtheria, Tetanus, And Pertussis (DTaP)), By Disease (Tetanus, Diphtheria), By End Use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Tetanus Toxoid Vaccine Market Growth & Trends The global tetanus toxoid vaccine market size is anticipated t%li%reach USD 8.09 bill...
January 2025
153 pages
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
US$ 2,999.00
The global travel vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% duri...
January 2025
129 pages
International Trade in Antisera and Other Blood Fractions: Trends and Prospects
US$ 820.00
The reports examine global antisera and other blood fractions market trends (historical, current and forecast) with respect to international trade including antisera and other blood fractions global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
170 pages
International Trade in Vaccines, Human Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, human use market trends (historical, current and forecast) with respect to international trade including vaccines, human use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vaccines, Veterinary Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, veterinary use market trends (historical, current and forecast) with respect to international trade including vaccines, veterinary use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
